original ) (raw )Significance of catalase-peroxidase (KatG) mutations in mediating isoniazid resistance in clinical strains of Mycobacterium tuberculosis
Nusrath Unissa
Journal of global antimicrobial resistance, 2018
View PDFchevron_right
Docking Simulations and QM/MM Studies between Isoniazid Prodrug, Catalase-Peroxidase (KatG) and S315T Mutant from Mycobacterium tuberculosis
Teodorico C. Ramalho
Computational and Mathematical Methods in Medicine, 2007
View PDFchevron_right
Wild-type catalase peroxidase vs G279D mutant type: Molecular basis of Isoniazid drug resistance in Mycobacterium tuberculosis
Aishwarya Pratap Singh
Gene, 2018
View PDFchevron_right
In Silico Analysis Of Isoniazid Resistance In Mycobacterium Tuberculosis
Nusrath Unissa
2014
View PDFchevron_right
Theoretical insights on the binding of isoniazid to the active site residues of Mycobacterium tuberculosis catalase-peroxidase
gerardo janairo
Tuberculosis, 2018
View PDFchevron_right
Mutations in catalase-peroxidase KatG from isoniazid resistant Mycobacterium tuberculosis clinical isolates: insights from molecular dynamics simulations
Rosilene Cardoso
Journal of Molecular Modeling, 2017
View PDFchevron_right
Mutation of katG in a clinical isolate of Mycobacterium tuberculosis: effects on catalase-peroxidase for isoniazid activation
Defi Natalia
The Ukrainian Biochemical Journal
View PDFchevron_right
Recombinant Mycobacterium tuberculosis KatG(S315T) Is a Competent Catalase‐Peroxidase with Reduced Activity toward Isoniazid
Stephen Naylor
The Journal of Infectious Diseases, 1997
View PDFchevron_right
The Tuberculosis Prodrug Isoniazid Bound to Activating Peroxidases
Isabel Macdonald
Journal of Biological Chemistry, 2007
View PDFchevron_right
Identification of katG mutations associated with high-level isoniazid resistance in Mycobacterium tuberculosis
Mory Traore
Antimicrobial agents …, 2010
View PDFchevron_right
Antitubercular Isoniazid and Drug Resistance of Mycobacterium tuberculosis — A Review
ivan morales
Archiv Der Pharmazie, 2002
View PDFchevron_right
Mutation as a Molecular Determinant for Isoniazid Resistance in Mycobacterium tuberculosis
Naing Tha
2017
View PDFchevron_right
Population genetics study of isoniazid resistance mutations and evolution of multidrug-resistant Mycobacterium tuberculosis
Magali Leon
Antimicrobial Agents and Chemotherapy, 2006
View PDFchevron_right
Antibiotic Resistance in Mycobacterium tuberculosis
Kalina Ranguelova
Journal of Biological Chemistry, 2009
View PDFchevron_right
Chemical disarming of isoniazid resistance in Mycobacterium tuberculosis
Fredrik Almqvist
Proceedings of the National Academy of Sciences, 2019
View PDFchevron_right
Insight to pyrazinamide resistance in Mycobacterium tuberculosis by molecular docking
Nusrath Unissa
View PDFchevron_right
Detection of novel coupled mutations in the katG gene (His276Met, Gln295His and Ser315Thr) in a multidrug-resistant Mycobacterium tuberculosis strain from Chennai, India, and insight into the molecular mechanism of isoniazid resistance using structural bioinformatics approaches
Parvathy Rajan
International Journal of Antimicrobial Agents, 2011
View PDFchevron_right
Overview on mechanisms of isoniazid action and resistance in Mycobacterium tuberculosis
Nusrath Unissa
Infection, Genetics and Evolution, 2016
View PDFchevron_right
Elucidating Isoniazid Resistance Using Molecular Modeling
Habibah Wahab
Journal of Chemical Information and Modeling, 2009
View PDFchevron_right
Binding of activated isoniazid with acetyl-CoA carboxylase from Mycobacterium tuberculosis
Nusrath Unissa
Bioinformation, 2011
View PDFchevron_right
Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases
ROHIT KUMAR
Journal of Biological Chemistry, 2009
View PDFchevron_right
The Role of N-Acetyl Transferases on Isoniazid Resistance from Mycobacterium tuberculosis and Human: An In Silico Approach
Elizabeth Luke
Tuberculosis and Respiratory Diseases
View PDFchevron_right
Study of mechanism of interaction of truncated isoniazid–nicotinamide adenine dinucleotide adduct against multiple enzymes of Mycobacterium tuberculosis by a computational approach
Shraddha Deshmukh
International Journal of Mycobacteriology, 2015
View PDFchevron_right
Oxidative Stress Increases Susceptibility of Mycobacterium tuberculosis to Isoniazid
Glenn Roberts
Antimicrobial Agents and Chemotherapy, 2002
View PDFchevron_right
Isolation of oxidative stress response mutants in Escherichia coli for their use as a genetic screen to identify new anti-mycobacterials as functional analogues of isoniazid
Suman Khanuja
World Journal of Microbiology and Biotechnology, 2006
View PDFchevron_right
Access channel residues Ser315 and Asp137 in Mycobacterium tuberculosis catalase-peroxidase (KatG) control peroxidatic activation of the pro-drug isoniazid
K Kristoffer Andersson
Chemical Communications, 2013
View PDFchevron_right
In Silico Analysis of S315T and S315R Mutations of Multidrug-resistant Mycobacterium tuberculosis Clinical Isolates from Karachi, Pakistan
SADIA ALAM
Jundishapur Journal of Microbiology
View PDFchevron_right
Identification and analysis of mutations in the katG gene in multidrug-resistant Mycobacterium tuberculosis clinical isolates
Tomasz Jagielski
Pneumonologia i alergologia polska, 2013
View PDFchevron_right
Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases BINDING STUDIES AND CRYSTAL STRUCTURE OF BOVINE LACTOPEROXIDASE WITH ISONIAZID AT 2.7 �� RESOLUTION
mau sinha
2010
View PDFchevron_right
Catalase Expression, katG, And MIC Of Isoniazid For Mycobacterium tuberculosis Isolates From SaO Paulo, Brazil
Lucilaine Ferrazoli
Journal of Infectious Diseases, 1995
View PDFchevron_right
Mode of Binding of the Tuberculosis Prodrug Isoniazid to Heme Peroxidases: BINDING STUDIES AND CRYSTAL STRUCTURE OF BOVINE LACTOPEROXIDASE WITH ISONIAZID AT 2.7 A RESOLUTION
Nagendra Singh
Journal of Biological Chemistry, 2010
View PDFchevron_right
Mutations in katG and inhA genes of isoniazid-resistant and -sensitive clinical isolates of Mycobacterium tuberculosis from cases of pulmonary tuberculosis and their association with minimum inhibitory concentration of isoniazid
indu jaiswal
Clinical Epidemiology and Global Health, 2017
View PDFchevron_right